发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 239 |
| CHINA MAINLAND | 55 |
| GERMANY (FED REP GER) | 55 |
| England | 49 |
| Japan | 27 |
| Netherlands | 23 |
| Canada | 22 |
| France | 17 |
| Italy | 16 |
| Austria | 14 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF CALIFORNIA SYSTEM | 30 |
| VANDERBILT UNIVERSITY | 25 |
| IMPERIAL COLLEGE LONDON | 22 |
| STANFORD UNIVERSITY | 20 |
| PENNSYLVANIA COMMONWEALTH SYSTEM OF HIG... | 19 |
| UNIVERSITY OF COLORADO SYSTEM | 19 |
| HARVARD UNIVERSITY | 18 |
| JUSTUS LIEBIG UNIVERSITY GIESSEN | 18 |
| UNIVERSITY OF ARIZONA | 17 |
| UNIVERSITY OF PENNSYLVANIA | 17 |
文章引用情况
1
Drug repositioning in pulmonary arterial hypertension: challenges and opportunities2
The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials3
Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?4
Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension5
Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension6
Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension7
Pulmonary hypertension subjects exhibit right ventricular transient exertional dilation during supine exercise stress echocardiography8
Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature9
A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti10
Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies